Credentials

“BioReg Consultancy is a highly reliable and fully dedicated advisor and a much valued part of our development team that successfully moved our lead product – a monoclonal antibody construct - from research into clinical trials Phase I in the EU and the USA.”
Rolf H. Günther MD, PhD, CEO, Affimed Therapeutics AG, Heidelberg

“BioReg Consultancy played a key role in successful management of submissions for plasma product applications of our company.”
Michael Soldan, PhD, Geschäftsbereichsleiter Medical/Regulatory Affairs, Biotest AG, Dreieich

“During the development phases of our vaccine candidates and biotechnological products Dr. Ute Krahl has been providing very valuable strategic advice in manufacturing and regulatory affairs matters. With her excellent strategic and hands-on support to the team VPM managed to develop a live recombinant vaccine from bench to man in less than four years.”
Bernd Eisele, MD, CEO Vakzine Projekt Management GmbH